To print this article, all you need is to be registered or login on Mondaq.com. In 2019, the Chair of the U.S. House Committee on Ways and Means (the "Committee") asked the Medicare Payment Advisory Commission ("MedPAC"), an independent congressional agency established in 1997 to advise Congress on issues affecting the Medicare program, to examine the role that private equity ("PE") plays in the Medicare program. More specifically, MedPAC was asked to examine the following four issues related to PE investment: Gaps in Medicare data that make it difficult to track PE investments in Medicare-participating providers; Business models that PE firms use when they invest in the